BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 23664955)

  • 1. Preclinical evaluation of [(18)F]JNJ42259152 as a PET tracer for PDE10A.
    Celen S; Koole M; Ooms M; De Angelis M; Sannen I; Cornelis J; Alcazar J; Schmidt M; Verbruggen A; Langlois X; Van Laere K; Andrés JI; Bormans G
    Neuroimage; 2013 Nov; 82():13-22. PubMed ID: 23664955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical evaluation of 18F-JNJ41510417 as a radioligand for PET imaging of phosphodiesterase-10A in the brain.
    Celen S; Koole M; De Angelis M; Sannen I; Chitneni SK; Alcazar J; Dedeurwaerdere S; Moechars D; Schmidt M; Verbruggen A; Langlois X; Van Laere K; Andrés JI; Bormans G
    J Nucl Med; 2010 Oct; 51(10):1584-91. PubMed ID: 20847170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of 18F-JNJ-42259152, a novel phosphodiesterase 10A PET tracer: kinetic modeling and test-retest study in human brain.
    Van Laere K; Ahmad RU; Hudyana H; Dubois K; Schmidt ME; Celen S; Bormans G; Koole M
    J Nucl Med; 2013 Aug; 54(8):1285-93. PubMed ID: 23843566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiosynthesis and initial characterization of a PDE10A specific PET tracer [18F]AMG 580 in non-human primates.
    Hwang DR; Hu E; Allen JR; Davis C; Treanor J; Miller S; Chen H; Shi B; Narayanan TK; Barret O; Alagille D; Yu Z; Slifstein M
    Nucl Med Biol; 2015 Aug; 42(8):654-63. PubMed ID: 25935386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical evaluation of a promising C-11 labeled PET tracer for imaging phosphodiesterase 10A in the brain of living subject.
    Liu H; Jin H; Yue X; Zhang X; Yang H; Li J; Flores H; Su Y; Perlmutter JS; Tu Z
    Neuroimage; 2015 Nov; 121():253-62. PubMed ID: 26216275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of carbon-11 and fluorine-18 labeled tracers for in vivo visualization of PDE10A.
    Ooms M; Celen S; Koole M; Langlois X; Schmidt M; De Angelis M; Andrés JI; Verbruggen A; Van Laere K; Bormans G
    Nucl Med Biol; 2014 Sep; 41(8):695-704. PubMed ID: 25002365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [18F]JNJ42259152 binding to phosphodiesterase 10A, a key regulator of medium spiny neuron excitability, is altered in the presence of cyclic AMP.
    Ooms M; Attili B; Celen S; Koole M; Verbruggen A; Van Laere K; Bormans G
    J Neurochem; 2016 Dec; 139(5):897-906. PubMed ID: 27664396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical Evaluation and Quantification of
    Khanapur S; van Waarde A; Dierckx RA; Elsinga PH; Koole MJ
    J Nucl Med; 2017 Mar; 58(3):466-472. PubMed ID: 27789720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of [
    Yang KC; Stepanov V; Amini N; Martinsson S; Takano A; Nielsen J; Bundgaard C; Bang-Andersen B; Grimwood S; Halldin C; Farde L; Finnema SJ
    Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):308-320. PubMed ID: 27817159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo assessment and dosimetry of 2 novel PDE10A PET radiotracers in humans: 18F-MNI-659 and 18F-MNI-654.
    Barret O; Thomae D; Tavares A; Alagille D; Papin C; Waterhouse R; McCarthy T; Jennings D; Marek K; Russell D; Seibyl J; Tamagnan G
    J Nucl Med; 2014 Aug; 55(8):1297-304. PubMed ID: 24898025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the binding properties of T-773 as a PET radioligand for phosphodiesterase 10A.
    Harada A; Suzuki K; Miura S; Hasui T; Kamiguchi N; Ishii T; Taniguchi T; Kuroita T; Takano A; Stepanov V; Halldin C; Kimura H
    Nucl Med Biol; 2015 Feb; 42(2):146-54. PubMed ID: 25451212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of Fluorine-Containing Phosphodiesterase 10A (PDE10A) Inhibitors and the In Vivo Evaluation of F-18 Labeled PDE10A PET Tracers in Rodent and Nonhuman Primate.
    Li J; Zhang X; Jin H; Fan J; Flores H; Perlmutter JS; Tu Z
    J Med Chem; 2015 Nov; 58(21):8584-600. PubMed ID: 26430878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of chronic voluntary alcohol consumption on PDE10A availability: a longitudinal behavioral and [
    de Laat B; Kling YE; Schroyen G; Ooms M; Hooker JM; Bormans G; Van Laere K; Ceccarini J
    Eur J Nucl Med Mol Imaging; 2022 Jan; 49(2):492-502. PubMed ID: 34142214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further evaluation of [11C]MP-10 as a radiotracer for phosphodiesterase 10A: PET imaging study in rhesus monkeys and brain tissue metabolite analysis.
    Lin SF; Labaree D; Chen MK; Holden D; Gallezot JD; Kapinos M; Teng JK; Najafzadeh S; Plisson C; Rabiner EA; Gunn RN; Carson RE; Huang Y
    Synapse; 2015 Feb; 69(2):86-95. PubMed ID: 25450608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human biodistribution and dosimetry of 18F-JNJ42259152, a radioligand for phosphodiesterase 10A imaging.
    Van Laere K; Ahmad RU; Hudyana H; Celen S; Dubois K; Schmidt ME; Bormans G; Koole M
    Eur J Nucl Med Mol Imaging; 2013 Jan; 40(2):254-61. PubMed ID: 23160998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initial characterization of a PDE10A selective positron emission tomography tracer [11C]AMG 7980 in non-human primates.
    Hwang DR; Hu E; Rumfelt S; Easwaramoorthy B; Castrillon J; Davis C; Allen JR; Chen H; Treanor J; Abi-Dargham A; Slifstein M
    Nucl Med Biol; 2014 Apr; 41(4):343-9. PubMed ID: 24607437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of two fluorine-18 labeled PET radioligands targeting PDE10A and in vivo PET evaluation in nonhuman primates.
    Stepanov V; Takano A; Nakao R; Amini N; Miura S; Hasui T; Kimura H; Taniguchi T; Halldin C
    Nucl Med Biol; 2018 Feb; 57():12-19. PubMed ID: 29223715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery and development of 11C-Lu AE92686 as a radioligand for PET imaging of phosphodiesterase10A in the brain.
    Kehler J; Kilburn JP; Estrada S; Christensen SR; Wall A; Thibblin A; Lubberink M; Bundgaard C; Brennum LT; Steiniger-Brach B; Christoffersen CT; Timmermann S; Kreilgaard M; Antoni G; Bang-Andersen B; Nielsen J
    J Nucl Med; 2014 Sep; 55(9):1513-8. PubMed ID: 24994928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical Evaluation of
    Declercq L; Rombouts F; Koole M; Fierens K; Mariën J; Langlois X; Andrés JI; Schmidt M; Macdonald G; Moechars D; Vanduffel W; Tousseyn T; Vandenberghe R; Van Laere K; Verbruggen A; Bormans G
    J Nucl Med; 2017 Jun; 58(6):975-981. PubMed ID: 28232614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A human [(11)C]T-773 PET study of PDE10A binding after oral administration of TAK-063, a PDE10A inhibitor.
    Takano A; Stenkrona P; Stepanov V; Amini N; Martinsson S; Tsai M; Goldsmith P; Xie J; Wu J; Uz T; Halldin C; Macek TA
    Neuroimage; 2016 Nov; 141():10-17. PubMed ID: 27423256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.